Personalized Medicine Industry

Biomarker and Companion Diagnostics Business Development Initiatives

CHC is capable of assisting business development teams to better understand the needs and priorities of biomarker developers within the academic setting. The size and scope of the body of work can range from a few data points among a limited number of individuals to a more in-depth look at a particular topic from hundreds of participants. Such a process can serve as a stand-alone project or can be combined with additional networking services.

CHC Luminary Express™

CHC has resources to help support the scientific boards of Personalized Medicine Companies. The Luminary Express can provide information to further validate thoughts/beliefs by a larger pool of luminaries within a given sector and can also prove vital for corporations that want to gain key thought leader opinions from a blinded position.

Physician Investigator Perception Studies

CROs (and Pharma companies) can benefit from opinions of PI’s regarding critical issues with respect to training needs, priorities and challenges. Such studies can target physicians with previous PI experience in order to isolate training improvement priority pathways. Alternatively, some CRO’s may seek to better channel business development opportunities through research targeting insight from physicians interested in becoming active in clinical trials in the future.